Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 10NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1Sleep Wake Disorders 1Pain 1Nausea 1

Interventions

Radiotherapy 5Analgesia 4Zoledronic Acid 2strontium chloride 1Vitamin D 1Therapeutics 1Strontium-89 1Samarium-153 1Radiosurgery 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Prednisone 1Palliative Care 1Observation 1Nutritional Support 1Neck Dissection 1Morphine 1Mitoxantrone 1Methadone 1Mental Status and Dementia Tests 1Interviews as Topic 1Ibandronic Acid 1Glutamine 1Gemcitabine 1Fibroblast Growth Factor 7 1Fatty Acids, Omega-3 1Duloxetine Hydrochloride 1Dextromethorphan 1Counseling 1Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pain × Methadone × Clear all
NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Canadian Cancer Trials Group

Phase 1 Terminated
8 enrolled

Nausea, Pain, Sleep Wake Disorders, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡